Abdul Ahad
King Saud University
177 Papers
588 Citations
Abdul Ahad is an academic researcher from King Saud University. The author has contributed to research in topics: Transdermal & Chemistry. The author has an hindex of 36, co-authored 172 publications. Previous affiliations of Abdul Ahad include Chittagong Veterinary and Animal Sciences University & Umeå University.
Chat about Author
Papers
Status of terpenes as skin penetration enhancers.
TL;DR: An overview of the investigations on the feasibility and application of terpenes as sorption promoters for improved delivery of drugs through skin is presented.
252
Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan
TL;DR: It could be concluded that the nanotransfersomes accentuates the transdermal flux of valsartan and could be used as a carrier for effective transDermal delivery of valartan.
182
Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
TL;DR: Solid lipid nanoparticles are an efficient carrier for ocular delivery of levofloxacin and other drugs and are found to be non-irritant and safe for topical ophthalmic use.
149
Development of transethosomes formulation for dermal fisetin delivery: Box–Behnken design, optimization, in vitro skin penetration, vesicles–skin interaction and dermatokinetic studies
Thasleem Moolakkadath,Mohd. Aqil,Abdul Ahad,Syed Sarim Imam,Babar Iqbal,Yasmin Sultana,Mohd Mujeeb,Zeenat Iqbal +7 more
TL;DR: Present study data revealed that the developed transethosomes vesicles formulation was found to be a potentially useful drug carrier for fisetin dermal delivery.
134
Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: Statistical optimization, characterization and pharmacokinetic assessment
TL;DR: The results suggest that nanoethosomes are an efficient carrier for transdermal delivery of valsartan, and are significantly superior in terms of, amount of drug permeated in the skin, with an enhancement ratio of 43.38 ± 1.37 when compared to rigid liposomes.
134